Mainstream Drugs Do Not Help Patients Recover From Disease
Although the US spends twice as much on healthcare as other high-income nations, the US remains the sickest first world country on earth. Compared to other developed countries, the US has the shortest life expectancy and highest infant mortality rate. Plagued with chronic degenerative diseases, the vast majority of American patients are treated with expensive drugs that only mask symptoms and are filled with side effects. These drugs have become the standard of care in countries all over the world. When patients do not recover from disease, they all end up in hospitals. Endless hospitalizations are bankrupting our healthcare systems and this has created a global healthcare crisis.
Many companies produce natural botanical medicines for acute and chronic disease. Herbal medicine treats the root cause of disease and the best botanical therapies reverse disease with sustained results and no side effects, plus they are significantly cheaper and faster to develop.
In 2004 the FDA developed guidelines for botanical therapies to become approved botanical drugs in the US. Just like conventional drugs, botanical drugs are prescribed to patients to treat disease and have insurance coverage. Unfortunately patients never find out about these treatments because botanical companies are neglected and do not have equal access to resources for clinical trials.
Enable Herbal Medicine to Flourish Globally
In 2016 the FDA relaxed botanical drug approval guidelines to catch up with global standards, creating a huge opportunity for the worldwide expansion of botanical medicine. The global botanical medicine industry is an open and untapped $300 billion market.
PhytaZenica ("fai-tuh-zeh-ni-kuh") is a healthcare tech company that provides digital products and services to accelerate the development and approval of natural herbal medicine. Our digital platform provides resources for botanical medicine clinical trials, drug approval and commercialization.
Led by a team of world-class healthcare and technology experts, PhytaZenica is driving the expansion of herbal medicine to transform global healthcare. PhytaZenica is:
The Meaning of "PhytaZenica"
The word “phyta” ("fai-tuh") is a suffix used in scientific names for plants. We are focused on driving the worldwide expansion of herbal medicine made from all-natural botanical ingredients.
Originating from the Slovenian, Serbian and Croatian languages, the word “zenica” means the “pupil” of the eye. In some cultures, the eyes symbolize a message of prophesy, literally seeing “a vision of the future”. We are always keeping an eye on the future.
PhytaZenica represents the future of botanical medicine. Together, we seek to:
PhytaZenica makes socially responsible medicine to solve the healthcare crisis by providing better treatments for patients worldwide. Join us and spread the word. The healthcare revolution is here.
Our Team
Jennifer Wong
Founder & Chief Executive Officer
Sam Nanayakkara
Technology & Strategy
Our Advisers
Paul Shotton
Finance Adviser
Kenneth Kayser
Fintech Adviser
Dr. Jean Wang
Botanical Medicine & Regulatory Adviser
Ashish Kumar Jain
Marketing Adviser
Contact Us
Send us a message for investment details or more information:
Copyright © 2022 PhytaZenica - All Rights Reserved